[Protective effect of cresacin in D-galactosamine-induced acute experimental hepatitis].
Antioxidant properties of cresacin were studied on the model of galactosamine hepatitis and on the isolated liver cells of white male rats. It has been shown, that cresacin in a dose of 20 mg/kg effectively inhibits the processes of lipid peroxidation induced by hepatotoxin. Cresacin also normalized some components of fermentative and non-enzymatic antioxidant system. In particular the indexes of the activity of superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase and the level of reduced glutathione, total phospholipids and ascorbic acid was increased for certain. In vitro, on the isolated hepatocytes, cresacin showed the dose-dependent antioxidant effect. This fact is confirmed by its property to inhibit the speed of formation of the malonic dialdehyde in the incubation medium.
Korda
M M
MM
Ternopil State Medical Academy.
D000085:Acetates / Q000627:therapeutic use*; D000208:Acute Disease; D000818:Animals; D000975:Antioxidants / Q000627:therapeutic use*; D056486:Chemical and Drug Induced Liver Injury / Q000188:drug therapy* / Q000209:etiology; D004338:Drug Combinations; D004983:Ethanolamines / Q000627:therapeutic use*; D005688:Galactosamine / Q000633:toxicity*; D066298:In Vitro Techniques; D015227:Lipid Peroxidation / Q000187:drug effects; D008099:Liver / Q000166:cytology / Q000187:drug effects; D008297:Male; D051381:Rats; D013237:Stereoisomerism
D000085:Acetates; D000975:Antioxidants; D004338:Drug Combinations; D004983:Ethanolamines; C047413:crezacin; D005688:Galactosamine
Zakhysna diia krezatsynu za hostroho eksperimental'noho hepatytu, indukovanoho D-halaktozaminom.